Plexus Corp. (NASDAQ:PLXS) Insider Michael J. Running Sells 1,250 Shares of Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) insider Michael J. Running sold 1,250 shares of the stock in a transaction on Friday, February 21st. The stock was sold at an average price of $138.62, for a total value of $173,275.00. Following the sale, the insider now owns 1,276 shares in the company, valued at approximately $176,879.12. This represents a 49.49 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Plexus Trading Down 1.4 %

Shares of PLXS stock opened at $134.31 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $172.89. The company has a market capitalization of $3.63 billion, a PE ratio of 31.16 and a beta of 0.89. The business’s fifty day moving average is $151.94 and its 200 day moving average is $145.48.

Plexus (NASDAQ:PLXSGet Free Report) last issued its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, equities research analysts anticipate that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on PLXS shares. Needham & Company LLC increased their target price on Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Stifel Nicolaus started coverage on Plexus in a research report on Tuesday, February 4th. They set a “hold” rating and a $152.00 target price on the stock. Benchmark restated a “buy” rating and set a $165.00 target price on shares of Plexus in a research report on Wednesday, January 22nd. Finally, StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Plexus has a consensus rating of “Moderate Buy” and an average price target of $163.00.

View Our Latest Report on PLXS

Institutional Investors Weigh In On Plexus

Institutional investors and hedge funds have recently made changes to their positions in the business. Creative Planning increased its stake in Plexus by 56.0% in the third quarter. Creative Planning now owns 14,616 shares of the technology company’s stock valued at $1,998,000 after acquiring an additional 5,245 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in Plexus by 158.0% in the third quarter. Assenagon Asset Management S.A. now owns 82,575 shares of the technology company’s stock valued at $11,289,000 after acquiring an additional 50,564 shares during the last quarter. Wealth Enhancement Advisory Services LLC bought a new position in Plexus in the third quarter valued at $208,000. Smith Group Asset Management LLC increased its stake in Plexus by 24.6% in the third quarter. Smith Group Asset Management LLC now owns 4,127 shares of the technology company’s stock valued at $564,000 after acquiring an additional 815 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in Plexus by 89.4% in the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock valued at $63,000 after acquiring an additional 219 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.